pelacarsen
How Cardiologists’ High Hopes for Two Drugs Were Dashed
–Rank now
#5Peak rank
1Days on list
46Score · 7d
Nov 8, 2026First seen
About “Pelacarsen”
Pelacarsen is an experimental antisense oligonucleotide drug designed to lower lipoprotein(a) levels in patients with cardiovascular disease. The drug targets the LPA gene that encodes apolipoprotein(a), a key component of lipoprotein(a). It was developed by Ionis Pharmaceuticals and Novartis.
From Wikipedia ↗, the free encyclopedia. Text available under CC BY-SA 4.0.
Trending history
pelacarsen was first seen on Google Trends · United Kingdom on Nov 8, 2026. Since then it has appeared in 1 check on 1 different day. Its best position was #5 of 10, reached on Nov 8, 08:50 UTC. It dropped off the list after Nov 8, 08:50 UTC.
Rank history
Position on Google Trends · United Kingdom at every check (lower is better).
Last 14 days
Best rank per day (UTC).
5
Oct 26today
Featured in
Archived daily, weekly and monthly lists that include this entry.
Google Trends UK 1 day, best #5
Questions
Is pelacarsen trending on Google Trends UK right now?
Not at the moment. It was last on the list on Nov 8, 08:50 UTC, after 1 day of trending.
What is the highest rank pelacarsen reached?
#5 on Google Trends · United Kingdom, on Nov 8, 08:50 UTC. Trendoday checks this list every 60 minutes.
How long has pelacarsen been trending?
It was first seen on Nov 8, 2026 and has been on the list on 1 day (1 check) since.
What is “pelacarsen”?
According to Wikipedia: Experimental antisense oligonucleotide drug for lowering lipoprotein(a).